Bone Morphogenetic Protein Market is Expected to Grow With a CAGR 3.1% by 2023 – Key Players are ProSpec, DePuySynthes, Medtronic, R&D Systems, Cellumed, Sigma-Aldrich Corporation & Ember Therapeutics

/COMUNICAE/

M2 PRESSWIRE-May 31, 2017-Bone Morphogenetic Protein Market is Expected to Grow With a CAGR 3.1% by 2023 – Key Players are ProSpec, DePuySynthes, Medtronic, R&D Systems, Cellumed, Sigma-Aldrich Corporation & Ember Therapeutics
(C)1994-2017 M2 COMMUNICATIONS

RDATE:31052017

Dublin – Research and Markets has announced the addition of the “Global Bone Morphogentic Protien Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023” report to their offering.

The bone morphogenetic proteins market is growing at a fast pace due to the rise in sports and road accidents injuries. The rising number of people who are suffering from spinal injuries together with a rise in surgical rates are primary drivers for the market. According to the National spinal cord injury statistical center, approx 314 million people in the U.S. suffered from spinal cord injuries in 2016.

The global bone morphogenetic protein market has enormous opportunity to increase its demand in emerging countries. The major challenge is the lack of professionals in the field of bone morphogenetic protein market, hampering the BMP market growth.The global bone morphogenetic proteins market is segmented on the basis of type and application. On the basis of type, the global bone morphogenetic protein market is sub divided into recombinant bone morphogenetic protein-7 (rhBMP-7) and recombinant bone morphogenetic protein-2 (rhBMP-2).

On the basis of application, the bone morphogenetic proteins market is sub divided into oral maxillofacial surgery, spinal fusion, reconstructive and trauma. Spinal fusion segment shows the largest market share globally due to various factors such as increasing demand for minimally invasive medical procedures, rise in sports injuries, rise in spinal injuries and the growing geriatric population etc.

Companies Mentioned

– Allosource
– Baxter International
– Depuy Synthes
– Integra Lifesciences Holdings Corporation
– Johnson & Johnson
– Medtronic Plc
– Musculoskeletal Transplant Foundation
– Nuvasive, Inc.
– Orthofix Holdings, Inc
– Smith & Nephew, Inc.
– Stryker Corporation
– Wright Medical Group N.V.
– Xtant Medical Holdings, Inc
– Zimmer Biomet Holdings, Inc.

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Market Segmentation

5. Competitive Landscape

6. Global Bone Morphogenetic Protein Market By Region

7. Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/45cd32/global_bone

Leave a Reply

Your email address will not be published. Required fields are marked *